BriaCell Therapeutics's total assets for Q2 2024 were $12.23M, a decrease of -34.31% from the previous quarter. BCTX total liabilities were $20.55M for the fiscal quarter, a 27.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.